Page last updated: 2024-11-03

pyrilamine and Carcinoma, Bronchogenic

pyrilamine has been researched along with Carcinoma, Bronchogenic in 1 studies

Pyrilamine: A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.
mepyramine : An ethylenediamine derivative that is ethylenediamine in which one of the amino nitrogens is substituted by two methyl groups and the remaining amino nitrogen is substituted by a 4-methoxybenzyl and a pyridin-2-yl group.

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Folco, G1
Bolla, M1
Santinelli, E1
Bianco, S1
Sestini, P1
Mezzetti, M1
Sala, A1

Other Studies

1 other study available for pyrilamine and Carcinoma, Bronchogenic

ArticleYear
Furosemide attenuates bronchial responsiveness to antigen challenge "in vitro".
    Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23

    Topics: Acetophenones; Acetylcholine; Bronchi; Bronchiectasis; Carcinoma, Bronchogenic; Dicarboxylic Acids;

1995